Skip to main content
OpenTrials

Clinical trial condition

Meningeal Neoplasms

Explore clinical trials studying Meningeal Neoplasms. Study availability and eligibility vary by location and protocol.

271 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Meningeal Neoplasms trial results

Active, Not Recruiting

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

NCT01892397

Conditions
Brain Cancer, Brain Diseases, Brain Neoplasms, +11 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Miami Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

NCT04460937

Conditions
Adenocarcinoma Of Esophagus, Brain Diseases, Brain Neoplasms, +80 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

NCT03604978

Conditions
Central Nervous System Neoplasms, Grade 2 Meningioma, Grade 3 Meningioma, +10 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors

NCT06462222

Conditions
Central Nervous System Neoplasms, Leptomeningeal Metastasis, Meningeal Carcinomatosis, +5 more
Locations
  • The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China
  • Huizhou First Hospital Affiliated to Guangdong Medical University Huizhou, Guangdong, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
  • Cancer Center, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine Beijing, China
View Trial Details

Related conditions